Objective
To achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses and single or multi-asset projects.
Management group
Syncona Investment Management Limited
Company website
Launch date
26/10/2012
Domicile
Guernsey
Fund manager
Chris Hollowood
Dividend frequency
Annually
Wind-up provisions
The Company has an unlimited life.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
716.93 1,224.37 110.20 188.20 -41.45 0 0.00 Jul 0.88 (31/03/2023)
Scroll

Dividends

Dividends declared in last 12 months

There have been no dividends in the last 12 months.

Performance (%)

Return type 1 year 3 years 5 years 10 years
Syncona Share price total return -30.7 -46.8 -53.2 -0.9
Biotechnology & Healthcare AIC sector Share price total return -3.1 -15.8 5.3 129.0
Scroll

Share structure

Number of shares
650,570,586

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 542,771 15,551,004 189,632,238 897,078,767
Average N/A 726,497 747,649 711,005
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.60 18.33 239.01 1,725.93
Average N/A 0.85 0.94 1.37
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GG00B8P59C08 SYNC GBX London Stock Exchange - MAIN
Chi-x Europe Limited
London Stock Exchange
Scroll

Top holdings

Data as at : 30/09/2023

Investment % of total assets
Quell Therapeutics Limited 7.3
SwanBio Therapeutics Limited 6.4
Beacon Therapeutics Holdings Limited1 6.2
Anaveon AG 5.4
Autolus Therapeutics plc 5.3
OMass Therapeutics Limited 3.6
Resolution Therapeutics Limited 3.2
Purespring Therapeutics Limited 2.9
Clade Therapeutics Inc 2.0
Cambridge Epigenetix Limited 1.6

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.